Login / Signup

Validity, reliability, responsiveness, and clinically meaningful change threshold estimates of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).

Nathan A ClarkeBrendon WongRachael LawranceAnders IngelgårdIngolf GriebschDavid CellaAndrew Trigg
Published in: Journal of patient-reported outcomes (2024)
This study provides evidence that the NFBSI-16 has desirable psychometric properties for use in clinical studies in aBC. It also provides estimates of group- and individual-level meaningful change thresholds to facilitate score interpretation in future aBC research.
Keyphrases
  • psychometric properties
  • cancer therapy
  • papillary thyroid
  • drug delivery
  • quality improvement
  • current status
  • squamous cell carcinoma
  • childhood cancer
  • patient reported